Illicit fentanyls in the opioid street market: desired or imposed?
- PMID: 30512204
- PMCID: PMC6548693
- DOI: 10.1111/add.14474
Illicit fentanyls in the opioid street market: desired or imposed?
Abstract
Background: Illicitly manufactured fentanyl and its analogues are appearing in countries throughout the world, often disguised as heroin or counterfeit prescription pills, with resulting high overdose mortality. Possible explanations for this phenomenon include reduced costs and risks to heroin suppliers, heroin shortages, user preferences for a strong, fast-acting opioid and the emergence of Dark Web cryptomarkets. This paper addresses these potential causes and asks three questions: (1) can users identify fentanyl; (2) do users desire fentanyl; and (3) if users want fentanyl, can they express this demand in a way that influences the supply?
Argument/analysis: Existing evidence, while limited, suggests that some users can identify fentanyl, although not reliably, and some desire it, but because fentanyl is frequently marketed deceptively as other drugs, users lack information and choice to express demand effectively. Even when aware of fentanyl's presence, drug users may lack fentanyl-free alternatives. Cryptomarkets, while difficult to quantify, appear to offer buyers greater information and competition than offline markets. However, access barriers and patterns of fentanyl-related health consequences make cryptomarkets unlikely sources of user influence on the fentanyl supply. Market condition data indicate heroin supply shocks and shortages prior to the introduction of fentanyl in the United States and parts of Europe, but the much lower production cost of fentanyl compared with heroin may be a more significant factor CONCLUSION: Current evidence points to a supply-led addition of fentanyl to the drug market in response to heroin supply shocks and shortages, changing prescription opioid availability and/or reduced costs and risks to suppliers. Current drug users in affected regions of the United States, Canada and Europe appear largely to lack both concrete knowledge of fentanyl's presence in the drugs they buy and access to fentanyl-free alternatives.
Keywords: Demand-led; fentanyl; heroin; illicit opioids; markets; prescription opioids; supply shock; supply-led.
© 2018 Society for the Study of Addiction.
Conflict of interest statement
Declaration of interests
None.
Comment in
-
'Policies that Punish the Powerless' in a supply-led illicit fentanyl market.Addiction. 2019 May;114(5):781-782. doi: 10.1111/add.14484. Epub 2018 Dec 4. Addiction. 2019. PMID: 30513550 No abstract available.
-
Fentanils: a serious threat to public health.Addiction. 2019 May;114(5):783-785. doi: 10.1111/add.14542. Epub 2019 Jan 18. Addiction. 2019. PMID: 30659693 No abstract available.
-
What should clinicians do as fentanyl replaces heroin?Addiction. 2019 May;114(5):782-783. doi: 10.1111/add.14522. Epub 2019 Jan 20. Addiction. 2019. PMID: 30661265 No abstract available.
-
Fentanyl: the many challenges ahead.Addiction. 2019 May;114(5):785-786. doi: 10.1111/add.14587. Epub 2019 Mar 15. Addiction. 2019. PMID: 30873700 Free PMC article. No abstract available.
References
-
- Suzuki J, El-Haddad S A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend 2017; 171: 107–16. - PubMed
-
- Hibbs J, Perper J, Winek CL An outbreak of designer drug-related deaths in Pennsylvania. JAMA 1991; 265: 1011–3. - PubMed
-
- National Institute on Drug Abuse (NIDA). Overdose Death Rates. 2018. August 2018 [cited 2018 8/21/18]. Available at: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-deat... (accessed 21 August 2018).